LPL Financial
TNGX icon

LPL Financial’s Tango Therapeutics TNGX Stock Holding History

LPL Financial’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$575K Buy
+18,410
New +$455K ﹤0.01% 4904
2026
Q1 		– Sell
-12,000
Closed -$106K – 6160
2025
Q4 		$106K Buy
+12,000
New +$103K ﹤0.01% 5581

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

LPL Financial's TNGX Position: Q2 2026 in Review

LPL Financial opened a new position in Tango Therapeutics (TNGX) in Q2 2026: 18,410 shares worth $575K. The stake represents ﹤0.01% of the portfolio and ranks #4904 among its holdings. This is a return to the name: LPL Financial previously reported a position in TNGX as recently as Q4 2025.

LPL Financial first reported a position in TNGX in Q4 2025 and has held it in 2 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • LPL Financial held 18,410 shares of Tango Therapeutics worth $575K as of Q2 2026.
  • Tango Therapeutics was a new LPL Financial position in Q2 2026.
  • Tango Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #4904 holding.
  • LPL Financial first reported a position in Tango Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.